BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 18189338)

  • 1. A rank-based sample size method for multiple outcomes in clinical trials.
    Huang P; Woolson RF; O'Brien PC
    Stat Med; 2008 Jul; 27(16):3084-104. PubMed ID: 18189338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjusting O'Brien's test to control type I error for the generalized nonparametric Behrens-Fisher problem.
    Huang P; Tilley BC; Woolson RF; Lipsitz S
    Biometrics; 2005 Jun; 61(2):532-9. PubMed ID: 16011701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplicity-adjusted sample size requirements: a strategy to maintain statistical power with Bonferroni adjustments.
    Leon AC
    J Clin Psychiatry; 2004 Nov; 65(11):1511-4. PubMed ID: 15554764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size determination based on rank tests in clinical trials.
    Wang H; Chen B; Chow SC
    J Biopharm Stat; 2003 Nov; 13(4):735-51. PubMed ID: 14584719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The appropriateness of the Wilcoxon test in ordinal data.
    Hilton JF
    Stat Med; 1996 Mar; 15(6):631-45. PubMed ID: 8731005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical usage of O'Brien's OLS and GLS statistics in clinical trials.
    Dallow NS; Leonov SL; Roger JH
    Pharm Stat; 2008; 7(1):53-68. PubMed ID: 17390306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On non-parametric and generalized tests for the two-sample problem with location and scale change alternatives.
    Podgor MJ; Gastwirth JL
    Stat Med; 1994 Mar 15-Apr 15; 13(5-7):747-58. PubMed ID: 8023047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sample size formula for the supremum log-rank statistic.
    Eng KH; Kosorok MR
    Biometrics; 2005 Mar; 61(1):86-91. PubMed ID: 15737081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Power analyses for negative binomial models with application to multiple sclerosis clinical trials.
    Rettiganti M; Nagaraja HN
    J Biopharm Stat; 2012; 22(2):237-59. PubMed ID: 22251172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Power and sample size calculation incorporating misspecifications of the variance function in comparative clinical trials with over-dispersed count data.
    Igeta M; Takahashi K; Matsui S
    Biometrics; 2018 Dec; 74(4):1459-1467. PubMed ID: 29579337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bayesian predictive sample size selection design for single-arm exploratory clinical trials.
    Teramukai S; Daimon T; Zohar S
    Stat Med; 2012 Dec; 31(30):4243-54. PubMed ID: 22807115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size calculation for the weighted rank statistics with paired survival data.
    Jung SH
    Stat Med; 2008 Jul; 27(17):3350-65. PubMed ID: 18205148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.
    Levin GP; Emerson SC; Emerson SS
    Biometrics; 2014 Sep; 70(3):556-67. PubMed ID: 24766094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some Issues of Sample Size Calculation for Time-to-Event Endpoints Using the Freedman and Schoenfeld Formulas.
    Abel UR; Jensen K; Karapanagiotou-Schenkel I; Kieser M
    J Biopharm Stat; 2015; 25(6):1285-311. PubMed ID: 25629760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian sample size determination for a clinical trial with correlated continuous and binary outcomes.
    Stamey JD; Natanegara F; Seaman JW
    J Biopharm Stat; 2013; 23(4):790-803. PubMed ID: 23786161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size computation for two-sample noninferiority log-rank test.
    Jung SH; Kang SJ; McCall LM; Blumenstein B
    J Biopharm Stat; 2005; 15(6):969-79. PubMed ID: 16279355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of adaptive designs: efficiency evaluation.
    Menon S; Chang M
    J Biopharm Stat; 2012; 22(4):641-61. PubMed ID: 22651106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test Statistics and Confidence Intervals to Establish Noninferiority between Treatments with Ordinal Categorical Data.
    Zhang F; Miyaoka E; Huang F; Tanaka Y
    J Biopharm Stat; 2015; 25(5):921-38. PubMed ID: 24919157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On sample size determination in multi-armed confirmatory adaptive designs.
    Wassmer G
    J Biopharm Stat; 2011 Jul; 21(4):802-17. PubMed ID: 21516570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.